Frontlight ResearchEarly access
Taking people in AustriaPhase 2
Epiflux trial for adults with focal epilepsy
Tests Epiflux in adults with focal epilepsy, a seizure disorder.
Key facts
- Who runs it
- Medical University Of Vienna
- Where
- Vienna, AustriaSee the site
- Registry title
- Epiflux
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 60 people, planned
- Started
- 15 Apr 2020
- Expected to end
- 1 Jun 2029
- Type of study
- Interventional
- Record updated
- 14 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with focal epilepsy. The record gives no other details.
- Age
- 18 years or older
- Sex
- All sexes can join
Where in Austria
- Medical University of ViennaVienna, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Epiflux trial for adults with focal epilepsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 14 October 2024